Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 229.02-59.12655.88-122.1254.92

What is the latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS is 229.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025229.02
Mar2024-59.12
Mar2023655.88
Mar2022-122.12
Mar202154.92

How is Core EBITDA Growth of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 229.02
Positive
Mar2024 -59.12
Negative
Mar2023 655.88
Positive
Mar2022 -122.12
Negative
Mar2021 54.92 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹6,928.7 Cr 3.3% -3% -25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.8% -7.5% -12.2% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr -0.6% -5.5% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr -2.5% 3.5% 21.1% Stock Analytics
CIPLA ₹106,946.0 Cr -3.7% -11.7% -8.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -0.7% -4.7% -5.1% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

3.3%

-3%

-25.7%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses